European Authorities Recommend Approval Of Wegovy For Obesity
The European Medicines Agency’s Committee for Medicinal Products for Human Use has recommended the authorization of Novo Nordisk A/S’s (NYSE:NVO) Wegovy for…
Novo Nordisk Shares Volatile Amid News Co. Sees Approval Of Its Wegovy Candidate For Treatment Of Obesity In Europe In 2 Months
https://www.novonordisk.com/content/nncorp/global/en/news-and-media/news-and-ir-materials/news-details.html?id=86334
Earnings Scheduled For November 3, 2021
Companies Reporting Before The Bell
• R.R.Donnelley & Sons (NYSE:RRD) is likely to report quarterly earnings at $0.32 per share on revenue of $1.19 billion.
Novo Nordisk Boosts FY21 Outlook After Solid Q3 Sales
Novo Nordisk A/S (NYSE:NVO) raised its forecast for sales and operating profit for FY21 after strong sales in Q3. The company…
Novo Nordisk Sees FY21 Sales Growth 12%-15%
https://view.news.eu.nasdaq.com/view?id=befacb1bcc7fd7886532bc9bc60c96d08&lang=en
Novo Nordisk Raises Guidance
https://view.news.eu.nasdaq.com/view?id=befacb1bcc7fd7886532bc9bc60c96d08&lang=en
Novo Nordisk Settles Insulin Pricing Lawsuit For $100M
Novo Nordisk A/S (NYSE:NVO) has agreed to pay $100 million to settle a 2017 investor suit that alleged the Company failed…
House Committee Questions Eli Lilly, Sanofi, Novo Nordisk On ‘Unacceptably High’ Insulin Prices
House Energy & Commerce Committee leaders sent three letters to execs at Eli Lilly And Co (NYSE:LLY), Sanofi SA (NASDAQ:SNY), and Novo Nordisk A/S (NYSE:NVO), raising…
Stocks That Hit 52-Week Highs On Friday
Before 10 a.m. ET on Friday, 52 companies hit new 52-week highs.